A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
PHASE2This study is an open, multicenter, dose-escalation and expansion, non-rand...
Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
PHASE1The objective of this study to evaluate the safety, tolerability, pharmacok...
A Study of BL-M11D1 in Patients With Relapsed/Refractory Myelodysplastic Syndromes
PHASE1This study is an open-label, multicenter, non-randomized Phase Ib/II clinic...
Location
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences